RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
151 hedge funds and large institutions have $1.49B invested in Revance Therapeutics, Inc. in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 45 reducing their positions, and 27 closing their positions.
Holders
151
Holders Change
-2
Holders Change %
-1.31%
% of All Funds
2.68%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
28
Increased
51
Reduced
45
Closed
27
Calls
$6.53M
Puts
$13.2M
Net Calls
-$6.68M
Net Calls Change
-$2.96M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$80.8M |
| 2 |
PAI
2
Palo Alto Investors
Palo Alto,
California
|
$75.8M |
| 3 |
3
AllianceBernstein
Nashville,
Tennessee
|
$86.9M |
| 4 |
4
UBS AM
Chicago,
Illinois
|
$10.6M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$123M |
